Theravance Biopharma to Participate in an Upcoming Investor Conference

Rhea-AI Summary

Theravance Biopharma, Inc. (TBPH) to participate in CNS Corporate Panel Discussion at TD Cowen 44th Annual Health Care Conference. Senior management to host one-on-one meetings. Webcast available on Theravance.com.

DUBLIN, Feb. 22, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in the CNS Corporate Panel Discussion at the TD Cowen 44th Annual Health Care Conference in Boston, MA on Tuesday, March 5 at 10:30 am ET (7:30 am PT/3:30 pm GMT). Members of Theravance Biopharma senior management will be hosting one on one meetings at the conference.

Webcast of the event may be accessed by visiting Theravance.com, under the Investors section, Events and Presentations. Replay of the webcast will be archived on the Company's website for 30 days.

About Theravance Biopharma

Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference^® in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI^® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Ampreloxetine, its late-stage investigational norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension, has the potential to be a first in class therapy effective in treating a constellation of cardinal symptoms in multiple symptom atrophy patients. The Company is committed to creating/driving shareholder value.

For more information, please visit www.theravance.com.

THERAVANCE BIOPHARMA^®, THERAVANCE^® and the Cross/Star logo are registered trademarks of the Theravance Biopharma group of companies (in the U.S. and certain other countries).

YUPELRI^® is a registered trademark of Mylan Specialty L.P., a Viatris company. Trademarks, trade names or service marks of other companies appearing in this press release are the property of their respective owners.

Contact:
investor.relations@theravance.com
650-808-4045

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/theravance-biopharma-to-participate-in-an-upcoming-investor-conference-302068341.html

SOURCE Theravance Biopharma, Inc.

FAQ

When will Theravance Biopharma participate in the CNS Corporate Panel Discussion?

Theravance Biopharma will participate in the CNS Corporate Panel Discussion at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5 at 10:30 am ET.

Where will the TD Cowen 44th Annual Health Care Conference take place?

The TD Cowen 44th Annual Health Care Conference will take place in Boston, MA.

How can the webcast of the event be accessed?

The webcast of the event may be accessed by visiting Theravance.com, under the Investors section, Events and Presentations.

For how long will the webcast replay be available on the Company's website?

The webcast replay will be archived on the Company's website for 30 days.